Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | N1 - Neuroscience in the Clinic: Neurobiology of Learning and Memory in 2022

Saturday 04/02/22
12:15 PM - 02:15 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Neuroscience in the Clinic Session
Joshua M. Shulman, MD, PhD, FAAN, Anna K. Gillespie, PhD
Aging, Dementia, Cognitive, and Behavioral Neurology, Movement Disorders
Participants will become familiar with neural mechanisms underlying memory processes and be introduced to novel stimulation-based and neurofeedback approaches being developed to promote memory-related brain activity in Alzheimer's and other diseases of aging. We will discuss how such strategies for manipulating brain activity hold promise for therapeutic benefit as well as shedding light on fundamental mechanisms of cognitive processes.
2.00 CME credits
Medical Knowledge
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
12:15 PM - 12:20 PM PDT Introduction Introduction
Joshua M. Shulman, MD, PhD, FAAN
12:15 PM - 02:15 PM PDT Speaker walk in slides
Joshua M. Shulman, MD, PhD, FAAN
12:20 PM - 12:50 PM PDT Speaker Invited Speaker
Annabelle Singer, PhD
12:50 PM - 01:05 PM PDT Abstract 001 - Feasibility, Safety, and Efficacy of Gamma Sensory Stimulation as a Novel Therapeutic Intervention for Alzheimer’s Disease
Mihaly Hajos, PhD
01:05 PM - 01:35 PM PDT Speaker Invited Speaker
Anna K. Gillespie, PhD
01:35 PM - 01:50 PM PDT Abstract 002 - Left Rostral Prefrontal Connectivity Links Thalamic Stimulation to Changes in Abstraction
Joey Hsu
01:50 PM - 02:15 PM PDT Discussion Q&A and Discussion
Joshua M. Shulman, MD, PhD, FAAN
Faculty Disclosures
Jonathan Thomas Megerian, MD, PhD Dr. Megerian has received personal compensation for serving as an employee of Yamo Pharmaceuticals. Dr. Megerian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics. Dr. Megerian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kuzani Pharmaceuticals. Dr. Megerian has received research support from Childrens Hospital of Orange County.
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara.
Mark Richardson Mark Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SetPoint Medical. Mark Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Mark Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Mark Richardson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Mark Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics.
Joshua M. Shulman, MD, PhD, FAAN Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Annabelle Singer, PhD An immediate family member of Annabelle Singer, PhD has received personal compensation for serving as an employee of OM1. An immediate family member of Annabelle Singer, PhD has received personal compensation for serving as an employee of Jvion. Annabelle Singer, PhD has stock in Cognito Therapeutic. The institution of Annabelle Singer, PhD has received research support from Cognito Therapeutics.
Martin Williams Martin Williams has received personal compensation for serving as an employee of Cognito Therapeutics. Martin Williams has received stock or an ownership interest from Cognito Therapeutics. Martin Williams has received intellectual property interests from a discovery or technology relating to health care.
Aylin Cimenser, PhD Dr. Cimenser has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. An immediate family member of Dr. Cimenser has received personal compensation for serving as an employee of Boston Scientific Corporation. Dr. Cimenser has stock in Cognito Therapeutics Inc. An immediate family member of Dr. Cimenser has stock in Boston Scientific Corporation. Dr. Cimenser has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Cimenser has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Cimenser has received publishing royalties from a publication relating to health care.
Mihaly Hajos, PhD Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care.
Zach Malchano Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics.
Joey Hsu The institution of Mr. Hsu has received research support from Walter L. Copeland Fund of the Pittsburgh Foundation.
Andreas Horn Andreas Horn has nothing to disclose.
Kim Kwan Mr. Kwan has nothing to disclose.
Alyssa Boasso, PhD Ms. Boasso has received personal compensation for serving as an employee of Cognito Therapeutics.
Evan R. Hempel Mr. Hempel has received personal compensation for serving as an employee of Cognito Therapeutics.
Jessie Johnson, PhD The institution of Dr. Johnson has received personal compensation in the range of $0-$499 for serving as a Consultant for Pentara Corporation.
Brent Vaughan Mr. Vaughan has received personal compensation for serving as an employee of Morningside . Mr. Vaughan has received personal compensation for serving as an employee of Kuzani Pharmaceuticals, Inc.. Mr. Vaughan has received personal compensation for serving as an employee of Cognito Therapeutics, Inc..
Colleen Mary Cotter Ms. Cotter has nothing to disclose.
Luke C. Henry, PhD Dr. Henry has nothing to disclose.
Dengyu Wang Mr. Wang has nothing to disclose.
Clemens Neudorfer, MD Dr. Neudorfer has nothing to disclose.
Anna K. Gillespie, PhD The institution of Anna K. Gillespie, PhD has received research support from National Institute of Health. Anna K. Gillespie, PhD has received intellectual property interests from a discovery or technology relating to health care.